15 Stocks with the Biggest Hedge Fund Momentum
On February 23, Bloomberg News reported that during the week ended February 19, hedge funds registered record-high net sales of global stocks, the highest since early April 2025.
Cogent Biosciences Inc. (COGT)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Deerfield Management James E. Flynn | 9,043,903 | $321,239,435 | -1% | 4.1% |
| 2. | Kynam Capital Derrick Tang | 6,165,223 | $218,988,721 | -22% | 13.99% |
| 3. | Vivo Capital Albert Cha And Frank Kung | 2,398,993 | $85,212,231 | -14% | 5.51% |
| 4. | Octagon Capital Advisors Ting Jia | 2,350,000 | $83,472,000 | -19% | 10.13% |
| 5. | D E Shaw D. E. Shaw | 2,247,804 | $79,841,998 | +47% | 0.04% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $9.00 | 2,777,777 | $24,999,993.00 | 9,003,418 | 2025-07-10 | Filing | |
| $7.60 | 43,750 | $332,412.50 | 45,848 | 2025-01-14 | Filing | |
| $12.00 | 800,000 | $9,600,000.00 | 3,272,124 | 2023-06-09 | Filing | |
| $8.25 | 1,200,000 | $9,900,000.00 | 2,472,124 | 2022-06-16 | Filing | |
| $2.62 | 101,000 | $264,620.00 | 4,355,273 | 2020-08-18 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $36.40 | 3,500,000 | $127,400,000.00 | 5,503,418 | 2026-01-22 | Filing | |
| $38.70 | 65,000 | $2,515,500.00 | 109,398 | 2025-12-26 | Filing | |
| $38.68 | 77,000 | $2,978,360.00 | 131,834 | 2025-12-26 | Filing | |
| $38.70 | 82,642 | $3,198,245.40 | 133,938 | 2025-12-26 | Filing | |
| $38.74 | 90,000 | $3,486,600.00 | 140,002 | 2025-12-26 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 23,086,967 | $820,049,063 | 0.04% | |
| 2. | 12,974,591 | $460,857,474 | 0.01% | |
| 3. | 11,514,326 | $408,988,860 | 0.01% | |
| 4. | 9,003,418 | $319,801,407 | 24.34% | |
| 5. | 7,592,241 | $269,676,400 | 2.7% |
News See All
Cogent Biosciences (COGT) Advances Bezuclastinib-Sunitinib Combination With Breakthrough Therapy Designation (BTD)
On January 26, 2026, Cogent Biosciences, Inc. (NASDAQ:COGT) announced a major milestone, receiving a Breakthrough Therapy Designation (BTD) by the U.S. Food and Drug Administration.
11 Best Performing Stocks in the Last 12 Months
The year 2025 was not just another year but a period marked by sharp shifts in technology, geopolitics, and trade policy, often driving markets in surprising ways, according to Reuters' year-end report...
H.C. Wainwright is Bullish on Cogent Biosciences, Inc. (COGT)
Based on a research note dated January 6, 2026, The Fly reported that H.C. Wainwright reaffirmed a Buy rating and lifted its price target for Cogent Biosciences, Inc. (NASDAQ:COGT) from $50 to $52.
JPMorgan Raises Cogent Biosciences (COGT) PT to $67 on Sector Model Update
Cogent Biosciences Inc. (NASDAQ:COGT) is one of the best emerging technology stocks to invest in.
12 Best Emerging Technology Stocks to Invest In
On December 24, Kevin Simpson of Capital Wealth Planning joined 'Closing Bell' on CNBC to talk about AI tailwinds and the diverging tech picture.
Will Cogent Biosciences’ (COGT) Breakthrough Therapy Transform GIST Treatment? Analysts Think So
Cogent Biosciences Inc. (NASDAQ:COGT) is among the hottest SMID-cap stocks so far in 2025. On November 13, H.C.
10 Hottest SMID-Cap Stocks So Far In 2025
SMID-caps, or Small- and mid-cap stocks, are often overlooked segments of the market.
Cogent Biosciences (COGT) Soars 126% on Stomach Cancer Treatment Progress
Cogent Biosciences skyrocketed by 126.3 percent week-on-week, as investor sentiment was boosted by the promising results of its last clinical trial that tested the efficacy of its drug candidate for a...